ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves concepts For Grants to Develop HPV Animal Models, ALL Etiology Contracts

March 11, 1988

Cancer Screening Priorities Questioned In Dartmouth Study

March 28, 2003

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009

Gene Therapy Experiments Get RDAC Okay

August 10, 1990